Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours - Archive ouverte HAL Access content directly
Journal Articles British Journal of Cancer Year : 2017

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

France Blanchard
  • Function : Author
Marianne Paresy
  • Function : Author
Lilian Schwarz
  • Function : Author
  • PersonId : 1035625

Abstract

Background: The direct comparison of CA19.9, circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) using endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) has never been performed for the diagnosis of solid pancreatic tumours (SPTs). Methods: We included 68 patients with a SPT referred for EUS-FNA. CTCs were analysed using size-based platform and ctDNA using digital PCR. The sensitivity, specificity, negative and positive predictive values were evaluated for each marker and their combination. Results: SPTs corresponded to 58 malignant tumours (52 pancreatic adenocarcinoma (PA) and 6 others) and 10 benign lesions. The sensitivity and specificity for PA diagnosis were 73% and 88% for EUS-FNA, 67% and 80% for CTC, 65% and 75% for ctDNA and 79% and 93% for CA19.9, respectively. The positivity of at least 2 markers was associated with a sensitivity and specificity of 78% and 91%, respectively. CtDNA was the only marker associated with overall survival (median 5.2 months for ctDNA þ vs 11.0 months for ctDNA , P 1⁄4 0.01). Conclusions: CA19.9 alone and in combination with ctDNA and/or CTC analysis may represent an efficient method for diagnosing PA in patients with SPTs. Further studies including a larger cohort of patients with both malignant and benign lesions will be necessary to confirm these promising results.
Fichier principal
Vignette du fichier
Sefrioui BJC 2017.pdf (954.97 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02377819 , version 1 (24-11-2019)

Identifiers

Cite

David Sefrioui, France Blanchard, Emmanuel Toure, Paul Basile, Ludivine Beaussire, et al.. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. British Journal of Cancer, 2017, 117, pp.1017-1025. ⟨10.1038/bjc.2017.250⟩. ⟨hal-02377819⟩
90 View
86 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More